(PDF) Thromboelastography Market Is Expected to Reach US$ 863.9 Million at a 7.2% CAGR By 2027

May 24, 2023

August 5th, 2021 Coherent Market Insights Releases

SEATTLE, August 05, 2021, (MEDGADGET) — Thromboelastography (TEG) is the viscoelastic hemostatic assay, which measures the properties of visco-elasticity of the formation of blood clots. It is majorly used within anesthesiology and surgery. The test is able to measure coagulation factor function. Amongst the other blood coagulation tests includes partial thromboplastin time (aPTT) and prothrombin time. However, thromboelastography offers information associated with all hemostasis components such as platelet function and coagulation. Moreover, TEG provides a specific advantage in the diagnosis of fibrinolysis. The machines of TEG are used to perform this test.

The global thromboelastography market size is estimated to account for at US$ 531.8 million in 2020 and is projected to witness a CAGR of 7.2% during the forecast period (2020-2027).

*The Sample consists of Table of Content, Research framework of the actual report & research methodology adopted for it. Download Free PDF Sample: https://www.coherentmarketinsights.com/insight/request-sample/2371

Global Thromboelastography Market – Drivers

Increasing patient populace having lifestyle-associated diseases and chronic blood disorders prevalence are expected to propel the global thromboelastography market growth during the forecast period. For instance, as per the American Cancer Society 2020, in the U.S. over 178,520 people are expected to be detected with lymphoma, myeloma or leukemia, in 2020.

Major players are focusing on adopting inorganic growth strategies including agreements and collaborations for strengthening their market position. For instance, Haemonetics Corporation, in April 2020, declared enicor GmbH's acquisition of ClotPro – a complete blood coagulation testing system manufacturer. The system is expected to propel its product capabilities including TEG 5000 Hemostasis Analyzer along with the TEG 6s Hemostasis Analyzer, and provide improved products within the market. The system of ClotPro decreases the annual pipetting need along with eliminating issues of reagent handling.

Global Thromboelastography Market – Restraints

Thromboelastography test is the highly sensitive and promising test to identify underlying coagulopathy succeeding traumatic brain injuries. However, the conventional coagulation tests (CCTs) confirmation is suggested, which is the lengthy and time consuming procedure.

Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2371

Furthermore, to perform an analysis of thromboelastography within a lab setting, the blood sample transportation for over 5 minutes is needed, which is maximum limit to run native samples of blood and thus, storing the blood samples within heparin or citrate becomes compulsory. The citrate storage use has been reported for influencing the thromboelastography analysis results. Thus, drawbacks of such types thromboelastography is expected to hamper the growth of the global thromboelastography market.

Global Thromboelastography Market – Coronavirus (Covid-19) Pandemic Impact

Patients infected with COVID-19 may endure high risk of having stroke, kidney failure, and other complications related to the formation of blood clots. As per the researchers at the University of Colorado Anschutz Medical Campus, Aurora, early assay of thromboelastography (TEG) may be helpful in identifying patients of COVID-19, who may require more therapies of anticoagulation for preventing complications of clot formation.

Furthermore, it is suggested that all COVID-19 patients should undergo studies of coagulation at admission, since there is notable increase in prothrombin and D-dimer with reduction in fibrinogen found within patients of COVID-19 who all are at a high risk (non-survivors at 10-14 days). This is expected to fuel coagulopathy screening test demand such as thromboelastography (TEG) assay along with other traditional coagulation tests within a clinical setting.

Rising COVID-19 prevalence, specifically among patients already having severe health disorders/conditions, is expected to drive growth of the global thromboelastography market. For instance, as per the 2020 from study Hypertension Research, severe cardiac injuries is the most commonly registered cardiovascular abnormality within COVID-19 patients, occurring in over 8–12% of the entire COVID-19 patients.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/thromboelastography-market-3339

Global Thromboelastography Market – Key Players

Key players functioning in the global thromboelastography market are Haemonetics Corporation, Instrumentation Laboratory, Medirox AB, Framar Hemologix srl, Life Diagnostica, and Diagnostica Stago.

Table of Content

Global Thromboelastography Market Research ReportSection 1: Global Thromboelastography Industry OverviewSection 2: Global Economic Impact on Thromboelastography IndustrySection 3: Global Market Competition by Industry ProducersSection 4: Global Productions, Revenue (Value), according to RegionsSection 5: Global Supplies (Production), Consumption, Export, Import, geographicallySection 6: Global Productions, Revenue (Value), Price Trend, Product TypeSection 7: Global Market Analysis, on the basis of ApplicationSection 8: Thromboelastography Market Pricing AnalysisSection 9: Market Chain, Sourcing Strategy, and Downstream BuyersSection 10: Strategies and key policies by Distributors/Suppliers/TradersSection 11: Key Marketing Strategy Analysis, by Market VendorsSection 12: Market Effect Factors AnalysisSection 13: Global Thromboelastography Market Forecast

Have a Look at Related Research Insights:

Demineralized Bone Matrix Market

Dental Suture Market

Peripherally Inserted Central Catheters Market

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights1001 4th Ave, #3200 Seattle, WA 98154, U.S.Email: [email protected] States of America: +1-206-701-6702United Kingdom: +44-020-8133-4027Japan: +050-5539-1737India: +91-848-285-0837

Sign up and submit a press release